Supplementary Data from Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Table 1. Patient characteristics of all six individuals with MDM2/4 amplifications who received immunotherapy. Supplemental Table 2. Patient characteristics among patients who received anti-PD-1/PD-L1 (N = 102) Supplemental Table 3. Patients with EGFR alterations and TTF less than 2 months on immunotherapy (N=8 of a total of 10 patients with EGFR alterations). Supplemental Table 4. Patients with DNM3TA alterations and TTF less than 2 months on immunotherapy (N=4 of a total of 5 patients with DNM3TA alterations). Supplemental Figure 1. Evaluation of tumor biopsy at the time of progression (Case #4). Supplemental Figure 2.A. Case #11 Supplemental Figure 2.B. Case #13
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361931063